Blood test may speed up sepsis treatment in ICUs
NCT ID NCT06958354
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 1,529 intensive care patients with sepsis to see if a blood marker called procalcitonin (PCT) can help identify the type of bacteria causing the infection. Researchers measured PCT levels within 24 hours of a positive blood culture. The goal was to see if PCT levels differ between Gram-positive, Gram-negative, and fungal infections, which could help doctors choose the right antibiotics sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose the right antibiotics faster for ICU patients with sepsis.
- What could go wrong
- This is an observational study, not a treatment trial. The results may not change practice directly, and procalcitonin levels can be influenced by other conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTEREMIA AND SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gulhane Training and Research Hospital
Ankara, Türkiye, 06010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Could one blood draw be enough to catch dangerous infections?
- Blood markers may foretell brain fog after sepsis